Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1 — Technorehab  

Myotonic Dystrophy Type 1 (DM1) Clinical Trial

Official title: Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1

Status Completed

Clinical Trial Summary

Myotonic Dystrophy type 1 (DM1) is a genetic multisystem disease causing muscle weakness and myotonia. As a result, upper limb function might become impaired. There are little research regarding rehabilitation and exercise for upper limb function in DM1. It is known from research on lower limb function in DM1 and other muscular dystrophies, that there are possibilities to improve function also in these deteriorating diseases. In this single subject experimental design study, 6-10 adults with DM1, who are at an inpatient rehabilitation center, will get intensive, but personally adapted senso- and robot assisted rehabilitation for arm- and hand function with Tyromotion Amadeo and Armeo Senso. These devices have previously been used in rehabilitation research for other neurological conditions. The participants will be followed up, and evaluated at a weekly basis, using video consultations. Fine motor skill dexterity test (9HPT) and the Nut and Bolt test will be used, and active range of motion (ROM) and muscle strenght and movement of upper limb will be measured. Furthermore, patient reported outcome measures (PROMS) on hand impairment and myotonia will be used, all with purpose to evaluate upper limb function.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Myotonic Dystrophy
• Myotonic Dystrophy Type 1 (DM1)

• NCT number: NCT05560438
• Study type: Interventional
• Source: University of Oslo
• Status: Completed
• Phase: N/A
• Start date: January 3, 2022
• Completion date: December 31, 2023